Patient Right to Know Drug Prices Act
Latest action · Oct 10, 2018 Became Public Law No: 115-263.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 14, 2018
- Passed SenateSep 17, 2018
- Passed HouseSep 25, 2018
- To the PresidentOct 1, 2018
- Became lawOct 10, 2018Public Law 115-263
Summary
Patient Right to Know Drug Prices Act
(Sec. 2) This bill amends the Public Health Service Act to prohibit a health insurance plan or pharmacy benefits manager from restricting a pharmacy from informing an enrollee of any difference between the out-of-pocket cost of a drug under the plan and the cost of the drug without health insurance coverage. (Such restrictions are commonly referred to as gag clauses.)
(Sec. 3) The bill also amends the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 to apply certain antitrust filing requirements for generic drug applicants to biosimilar biological product applicants. (Biosimilar biological products, commonly referred to as biosimilars, are biological products approved by the Food and Drug Administration based on their similarity to an already-approved biological product.) Under current law, generic drug applicants that make agreements with brand name drug companies or other generic drug applicants regarding the manufacture, marketing, or sale of their drugs must file such agreements with the Federal Trade Commission and the Department of Justice. The bill subjects biosimilar biological product applicants to the same filing requirements.
Recorded votes 1
Newest first. Open one to see how every member voted.
Cosponsors 25
Members who signed on, in the order they did. Signatures ran from Mar 14, 2018 to Sep 17, 2018; 4 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-LA | Bill Cassidy | Original | Mar 14, 2018 |
| D-MO | Claire McCaskill | Original | Mar 14, 2018 |
| D-MI | Debbie Stabenow | Original | Mar 14, 2018 |
| R-WY | John Barrasso | Original | Mar 14, 2018 |
| D-MN | Tina Smith | Jun 7, 2018 | |
| D-IN | Joe Donnelly | Jun 11, 2018 | |
| D-CA | Dianne Feinstein | Jul 9, 2018 | |
| R-AK | Lisa Murkowski | Jul 19, 2018 | |
| D-NJ | Robert Menendez | Jul 19, 2018 | |
| D-WI | Tammy Baldwin | Jul 24, 2018 | |
| R-LA | John Kennedy | Jul 25, 2018 | |
| D-NH | Margaret Wood Hassan | Jul 25, 2018 | |
| D-CT | Richard Blumenthal | Jul 30, 2018 | |
| D-ND | Heidi Heitkamp | Aug 1, 2018 | |
| R-MS | Roger F. Wicker | Aug 1, 2018 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Health, Education, Labor, and Pensions Committee | Referred Mar 14, 2018Markup Jul 25, 2018Reported Jul 31, 2018 |
Actions 18
Everything that happened, newest first.
- Oct 10, 2018Signed by President.
- Oct 10, 2018Became Public Law No: 115-263.
- Oct 1, 2018Presented to President.
- Sep 25, 2018Mr. Carter (GA) moved to suspend the rules and pass the bill.
- Sep 25, 2018Considered under suspension of the rules. (consideration: CR H8795-8799)
In the Congressional Record 5
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S7221 | Chuck Grassley R-IA | Nov 29, 2018 |
| House | Debate and remarks H8795–H8799Text printed H8795 | Earl L. "Buddy" Carter R-GA, Frank Pallone, Jr. D-NJ, Greg Walden R-OR, John P. Sarbanes D-MD, Lloyd Doggett D-TX | Sep 25, 2018 |
| Senate | Debate and remarks S6164, S6170–S6173, S6175, S6176, S6178Amendments S6179Recorded votes S6179, S6180enactLee amendment (ensure self-insured group health insurance plans that are exempt from State regulations do not prohibit pharmacy providers from providing certain information to enrollees) | Bill Cassidy R-LA, Claire McCaskill D-MO, Dianne Feinstein D-CA, John Barrasso R-WY, Lamar Alexander R-TN, Mike Lee R-UT (amendment), Mitch McConnell R-KY, Susan M. Collins R-ME | Sep 17, 2018 |
| Senate | Debate and remarks S6105Amendments S6062 | Mike Lee R-UT (amendment), Mitch McConnell R-KY | Sep 6, 2018 |
| Senate | Debate and remarks S2664–S2667 | Joe Donnelly D-IN, Susan M. Collins R-ME | May 15, 2018 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Congressional Budget Office cost estimate
- Sep 12, 2018S. 2554, Patient Right to Know Drug Prices ActAs reported by the Senate Committee on Health, Education, Labor, and Pensions on July 31, 2018
CRS reports 6
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 6
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R44832 | Frequently Asked Questions About Prescription Drug Pricing and Policy | Report | May 6, 2021 |
| R44620 | Biologics and Biosimilars: Background and Key Issues | Report | Jun 6, 2019 |
| R45405 | The SUPPORT for Patients and Communities Act (P.L. 115-271): Food and Drug Administration and Controlled Substance Provisions | Report | Nov 15, 2018 |
| R43092 | Implementing EPA’s 2015 Ozone Air Quality Standards Archived | Report | Aug 16, 2018 |
| R44744 | Clean Air Act Issues in the 115th Congress: In Brief Archived | Report | Aug 13, 2018 |
Amendments 1
Amendments offered to this bill.
| Amendment | Description | Offered by | Status |
|---|---|---|---|
| SA 4011 | To limit application of the gag clause to self-insured group health plans. | Mike Lee R-UT | Amendment SA 4011 not agreed to in Senate by Yea-Nay Vote. 11 - 89. Record Vote Number: 208. |
Related bills 3
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 2553 | Know the Lowest Price Act of 2018 | Related bill | Oct 10, 2018 |
| HR 6143 | Patient Right to Know Drug Prices Act | Identical bill | Jun 19, 2018 |
| HR 6733 | Know the Cost Act of 2018 | Related bill | Sep 13, 2018 |
Titles 8
Every title it has carried, official and short, at each stage.
- Official Title
- An act to ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees
- Short Title
- Patient Right to Know Drug Prices Act
- Official Title as Introduced
- A bill to ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees.
- Short Titles as Introduced
- Patient Right to Know Drug Prices Act
- Short Titles as Reported to Senate
- Patient Right to Know Drug Prices Act
- Short Titles as Passed House
- Patient Right to Know Drug Prices Act
- Short Titles as Passed Senate
- Patient Right to Know Drug Prices Act
- Short Titles as Enacted
- Patient Right to Know Drug Prices Act
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 4
Each version as it was printed, newest first.
- —Enrolled Bill
- Sep 17, 2018Engrossed in Senate
- Jul 31, 2018Reported to Senate
- Mar 14, 2018Introduced in Senate
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.